Chene Gardner
Finanzdirektor/CFO bei SCORPEX, INC.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Kenneth Denos | M | 56 |
Synerteck, Inc.
| 25 Jahre |
| John Darrow Thomas | M | 47 | 12 Jahre | |
| Joseph Darold Caywood | M | 49 | - | |
| Ian Jenkins | M | 40 | 7 Jahre | |
| Larson Elmore | M | - | - | |
| David Baum | M | - | 8 Jahre | |
| Sean Martin | M | - | 8 Jahre | |
| Jun Liang | M | - | 5 Jahre | |
| Erwin Vahlsing | M | 67 | - | |
| Anthony Roger Moore | M | 76 | 3 Jahre | |
| David Kugelman | M | - | - | |
| Kevin Blanco | M | - | 12 Jahre | |
| Kyle M. Denos | M | - | - | |
| Aubrey Oliver | M | 59 | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Mark Daniel Klok | M | 48 | 8 Jahre | |
| Juan-Carlos Ley | M | 53 | - | |
| Scott Weissman | M | 46 | 1 Jahre | |
| Lee R. Rice | M | 80 | 2 Jahre | |
| Jim E. Frazier | M | 59 | - | |
| Thomas McConnell | M | 61 | 2 Jahre | |
| Russell Bruce Adler | M | 63 | 1 Jahre | |
| Maryorie Michelle Rivas Batista | M | - | - | |
| Norris R. Harris | M | 90 | - | |
| Ralph Robert Catala | M | 65 | - | |
| David Zimmerman | M | - | - | |
| Lorne Kalisky | M | 54 | - | |
| Corey Safran | M | 55 | - | |
| George J. Edwards | M | 76 | 2 Jahre | |
| Whit Tehan | M | - | - | |
| Joseph Toro | M | 38 | 1 Jahre | |
| Clayton B. Barlow | M | 52 |
Cancer Therapeutics, Inc.
 Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT.
Synerteck, Inc.
| 6 Jahre |
| Paul Douglas Major | M | 71 | 1 Jahre | |
| Randall S. Appel | M | - | - | |
| Cyrus J. Boga | M | 56 | 3 Jahre | |
| Stephen Arne D. Greaves | M | 59 | - | |
| Ruben Flores | M | 46 | 3 Jahre | |
| Douglas McFarland | M | 80 | - | |
| Jackie Stephens | M | 58 | - | |
| David J. Kovacs | M | 38 | - | |
| Mirta Mojica de Quintero | M | - | - | |
| Scott Bouslog | M | 62 | 1 Jahre | |
| Paul R. Donaldson | M | 79 | - | |
| David Zirulnikoff | M | 49 | - | |
| Walter Pera | M | 79 | 8 Jahre | |
| John D. Thomas | M | - |
Cancer Therapeutics, Inc.
Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT. | - |
| Kristina Hammonds | F | - | - | |
| Sean E. Wagner | M | 51 | - | |
| Robert K. Oldham | M | - |
Cancer Therapeutics, Inc.
Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT. | - |
| Michael K. Low | M | - |
Cancer Therapeutics, Inc.
Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT. | - |
| Daniel Reshef | M | 73 | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 50 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Chene Gardner
- Persönliches Netzwerk